Concepedia

Timo Schinkoethe

TS

6

Publications

228

Citations

6

H-Index

2013

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

Deutsches Archäologisches Institut, Zentrale

Timo Schinkoethe is an author at Ludwig-Maximilians-Universität München specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

2013–2021

6

Publications

6

WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial

Daniel Hofmann, Ulrike Nitz, Oleg Gluz et al. · Trials · 2013 · 114 citations · Full text

EHealth Acceptance and New Media Preferences for Therapy Assistance Among Breast Cancer Patients

Caroline Drewes, T Kirkovits, Daniel Schiltz et al. · JMIR Cancer · 2016 · 44 citations · Full text

Patient-reported outcome measures obtained via E-Health tools ease the assessment burden and encourage patient participation in cancer care (PaCC Study)

Nicole Erickson, Timo Schinkoethe, Carla Eckhardt et al. · Supportive Care in Cancer · 2021 · 20 citations · Full text

ADAPTcycle: Adjuvant dynamic marker-adjusted personalized therapy (ADAPT) comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer (EBC).

Nadia Harbeck, Oleg Gluz, Matthias Christgen et al. · Journal of Clinical Oncology · 2020 · 18 citations

, , +14

eHealth in Modern Patient-Caregiver Communication: High Rate of Acceptance Among Physicians for Additional Support of Breast Cancer Patients During Long-Term Therapy

T Kirkovits, Timo Schinkoethe, Caroline Drewes et al. · JMIR Cancer · 2016 · 17 citations · Full text

Rows per page

1–5 of 6